Cargando…
Engineering synthetic antibody binders for allosteric inhibition of prolactin receptor signaling
BACKGROUND: Many receptors function by binding to multiple ligands, each eliciting a distinct biological output. The extracellular domain of the human prolactin receptor (hPRL-R) uses an identical epitope to bind to both prolactin (hPRL) and growth hormone (hGH), yet little is known about how each h...
Autores principales: | Rizk, Shahir S, Kouadio, Jean-Louis K, Szymborska, Anna, Duguid, Erica M, Mukherjee, Somnath, Zheng, Jiamao, Clevenger, Charles V, Kossiakoff, Anthony A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4300558/ https://www.ncbi.nlm.nih.gov/pubmed/25589173 http://dx.doi.org/10.1186/s12964-014-0080-8 |
Ejemplares similares
-
Targeted rescue of cancer-associated IDH1 mutant activity using an engineered synthetic antibody
por: Rizk, Shahir S., et al.
Publicado: (2017) -
Allosteric Control of Ligand Binding Affinity Using Engineered Conformation-Specific Effector Proteins
por: Rizk, Shahir S., et al.
Publicado: (2011) -
Engineered Ultra-High Affinity Synthetic Antibodies for SARS-CoV-2 Neutralization and Detection
por: Slezak, Tomasz, et al.
Publicado: (2021) -
Engineering of a synthetic antibody fragment for structural and functional studies of K(+) channels
por: Rohaim, Ahmed, et al.
Publicado: (2022) -
Predicting antibody binders and generating synthetic antibodies using deep learning
por: Lim, Yoong Wearn, et al.
Publicado: (2022)